Claris Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$843K Sell
917
-20
-2% -$20.3K 0.46% 59
2025
Q4
$1.01M Buy
937
+72
+8% +$68.8K 0.54% 47
2025
Q3
$660K Sell
865
-36
-4% -$26.8K 0.37% 63
2025
Q2
$702K Sell
901
-23
-2% -$17.9K 0.53% 54
2025
Q1
$713K Hold
924
0.47% 52
2024
Q4
$713K Buy
+924
New +$765K 0.47% 52

Other funds holding LLY

Claris Financial's LLY Position: Q1 2026 in Review

Claris Financial reduced its Eli Lilly (LLY) stake by 2.1% in Q1 2026, selling an estimated $20.3K and leaving 917 shares worth $843K. The position accounts for 0.46% of the portfolio, ranked #59.

Claris Financial first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.01M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Claris Financial held 917 shares of Eli Lilly worth $843K as of Q1 2026.
  • Claris Financial sold 20 Eli Lilly shares in Q1 2026, an estimated $20.3K.
  • Eli Lilly made up 0.46% of Claris Financial's portfolio in Q1 2026, its #59 holding.
  • Claris Financial first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Claris Financial's Eli Lilly position peaked at $1.01M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Claris Financial's 13F filing for Q1 2026, filed 18 May 2026.